Clin2
NCT06989853Possibly a fitRecruiting

Testing troriluzole for methamphetamine use disorder

Methamphetamine Use Disorder

Treatments studied

Part of Mental health clinical trials.

This study tests whether a medication called troriluzole can help people who use methamphetamine. If you have methamphetamine use disorder and are not seeking treatment right now, this study may be an option for you.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
40 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are 18 to 55 years old
  • You have used methamphetamine recently and have a diagnosis of methamphetamine use disorder
  • You are not currently trying to quit or get treatment for drug use
  • You are generally healthy (aside from methamphetamine use) and not taking daily prescription medicines for a chronic condition
  • You do not have high blood pressure, a history of seizures, diabetes, asthma, or other serious medical or mental health conditions
  • If you are a woman, you must use effective birth control and not be pregnant or breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07226596Recruiting
Methamphetamine use: can you reduce without quitting?

This study tests whether people who use methamphetamine can reduce use even if they are not completely abstinent. It offers a 12-week program and checks how you're doing for another 12 weeks after.

Lexington, Kentucky
NCT07086014Recruiting
Brain response to methamphetamine cues in men

This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.

New York, New York
NCT06788587Recruiting· Phase 2
Long-term stimulant for methamphetamine recovery

This study tests whether a high dose of a stimulant medication (lisdexamfetamine, an ADHD medicine) taken over many weeks can help people who have already completed a methamphetamine treatment program to stay off meth, reduce use, or avoid relapse.

Montreal, Quebec
NCT07774702Not yet recruiting· Phase 2
Psilocybin for methamphetamine use disorder

This trial tests whether a psychedelic drug called psilocybin can help people cut down or stop using methamphetamine. You'll take the drug in a supervised setting and get support to aim for full abstinence.

Birmingham, Alabama
NCT06899594Recruiting· Early Phase 1
Psilocybin for quitting methamphetamine

This trial tests whether psilocybin (a psychedelic medicine) can help people quit methamphetamine. You'll receive counseling before, during, and after the drug session, and your progress will be followed for several months.

Shreveport, Louisiana
NCT06578429Recruiting
Deep TMS for methamphetamine use disorder

This study uses a type of brain stimulation called deep TMS to see if it can help people with methamphetamine use disorder reduce their cravings and use. You would receive daily magnetic pulses to specific brain areas over several weeks.

Palo Alto, California

Hear when a new Methamphetamine Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.